• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchErasca
    Picture of Erasca logo

    ERAS — Erasca Share News

    $14.870.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapMomentum Trap
    • Market Cap
      $5.20bn
    • Enterprise Value
      $4.93bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ERAS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ERAS Dividends
    • U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics

      28/04/2026 16:39
    • U.S. STOCKS ON THE MOVE- Kimberly-Clark, JetBlue, Amgen

      28/04/2026 14:09
    • Erasca shares sink after patient death in early-stage cancer drug trial (updated)

      28/04/2026 12:52
    • U.S. STOCKS ON THE MOVE-UPS, Centene, Coca-Cola

      28/04/2026 12:45
    • Erasca shares sink after patient death in early-stage cancer drug trial

      28/04/2026 11:07
    • Erasca drops after patient death reported in early cancer trial

      28/04/2026 11:04
    • Brief: Erasca Inc Revolution Medicines Alleges Erasca's Eras-0015 Infringes U.S. Patent No. 12,409,225

      27/04/2026 14:10
    • NASDAQ RESUMED AT 09:49 AM

      13/04/2026 14:49
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM

      13/04/2026 14:44
    • NASDAQ RESUMED AT 09:43 AM

      13/04/2026 14:43
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

      13/04/2026 14:33
    • Erasca Q4 net loss narrows as expenses fall

      12/03/2026 20:23
    • Brief: Erasca Q4 Basic EPS USD -0.1

      12/03/2026 20:01
    • Erasca rises on partnership with Tango to test new cancer drug combo

      05/03/2026 17:57
    • Brief: Erasca And Tango Therapeutics Enter Into Clinical Collaboration To Evaluate Combination Of ERAS-0015 And Vopimetostat

      05/03/2026 12:02
    • Erasca continues ascent after cancer therapy co's upsized $225 mln stock offering

      22/01/2026 12:18
    • Brief: Erasca Announces Pricing Of Upsized Public Offering Of Common Stock

      22/01/2026 01:56
    • Brief: Erasca Announces Proposed Public Offering Of $150 Million Of Common Stock

      20/01/2026 21:56
    • Cancer therapy firm Erasca drops after $150 mln stock offering unveil

      20/01/2026 21:46
    • Brief: Erasca Inc - Reports Promising Early Clinical Data For ERAS-0015

      12/01/2026 13:24
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.